Serial determination of serum IL-6, TNF-α, and IL-17 in a patient with rheumatoid arthritis successfully treated with kampo medicine: Case report and literature review

Autor:	Naoyuki Harada, Kanoko Yamamoto, Takeshi Tatsumi, Toshiaki Kogure
Rok vydání:	2015
Předmět:	biology business.industry Kampo Bucillamine Interleukin medicine.disease Rheumatoid arthritis Immunology medicine biology.protein Prednisolone Tumor necrosis factor alpha Interleukin 17 Interleukin 6 business medicine.drug
Zdroj:	Traditional & Kampo Medicine. 3:75-78
ISSN:	2053-4515
DOI:	10.1002/tkm2.1033
Popis:	Case A 68-year-old woman with rheumatoid arthritis (RA) who was being treated with prednisolone (PSL) and bucillamine (Buc) presented to request kampo medicine. Outcome Treatment with keishinieppiittokaryojutsubu (KER) in addition to PSL and Buc resulted in a favorable response based on the disease activity score 28-C-reactive protein, as well as a decrease in the serum levels of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-17 after 5 month. Furthermore, we discontinued PSL approximately 15 months later. Conclusion The mechanism of action of KER involves immunomodulation through not only IL-6 but also IL-17 in RA patients responding to KER.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ee18dc0002b0e5f0957a78922c04a3f1 https://doi.org/10.1002/tkm2.1033 Zobrazit plný text záznamu Plný text